141 related articles for article (PubMed ID: 33094790)
41. Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro.
Palm ME; Weise CF; Lundin C; Wingsle G; Nygren Y; Björn E; Naredi P; Wolf-Watz M; Wittung-Stafshede P
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6951-6. PubMed ID: 21482801
[TBL] [Abstract][Full Text] [Related]
42. Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?
Forbes JR; Cox DW
Am J Hum Genet; 1998 Dec; 63(6):1663-74. PubMed ID: 9837819
[TBL] [Abstract][Full Text] [Related]
43. Interactions between copper-binding sites determine the redox status and conformation of the regulatory N-terminal domain of ATP7B.
LeShane ES; Shinde U; Walker JM; Barry AN; Blackburn NJ; Ralle M; Lutsenko S
J Biol Chem; 2010 Feb; 285(9):6327-36. PubMed ID: 20032459
[TBL] [Abstract][Full Text] [Related]
44. Copper-dependent protein-protein interactions studied by yeast two-hybrid analysis.
van Dongen EM; Klomp LW; Merkx M
Biochem Biophys Res Commun; 2004 Oct; 323(3):789-95. PubMed ID: 15381069
[TBL] [Abstract][Full Text] [Related]
45. Conformational dynamics of metal-binding domains in Wilson disease protein: molecular insights into selective copper transfer.
Rodriguez-Granillo A; Crespo A; Wittung-Stafshede P
Biochemistry; 2009 Jun; 48(25):5849-63. PubMed ID: 19449859
[TBL] [Abstract][Full Text] [Related]
46. Metallothionein is elevated in liver and duodenum of Atp7b
Zhang CC; Volkmann M; Tuma S; Stremmel W; Merle U
Biometals; 2018 Aug; 31(4):617-625. PubMed ID: 29732486
[TBL] [Abstract][Full Text] [Related]
47. Role of the copper-binding domain in the copper transport function of ATP7B, the P-type ATPase defective in Wilson disease.
Forbes JR; Hsi G; Cox DW
J Biol Chem; 1999 Apr; 274(18):12408-13. PubMed ID: 10212214
[TBL] [Abstract][Full Text] [Related]
48. Cellular copper levels determine the phenotype of the Arg875 variant of ATP7B/Wilson disease protein.
Gupta A; Bhattacharjee A; Dmitriev OY; Nokhrin S; Braiterman L; Hubbard AL; Lutsenko S
Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5390-5. PubMed ID: 21406592
[TBL] [Abstract][Full Text] [Related]
49. Human copper-transporting ATPase ATP7B (the Wilson's disease protein): biochemical properties and regulation.
Lutsenko S; Efremov RG; Tsivkovskii R; Walker JM
J Bioenerg Biomembr; 2002 Oct; 34(5):351-62. PubMed ID: 12539962
[TBL] [Abstract][Full Text] [Related]
50. The N-terminal metal-binding site 2 of the Wilson's Disease Protein plays a key role in the transfer of copper from Atox1.
Walker JM; Huster D; Ralle M; Morgan CT; Blackburn NJ; Lutsenko S
J Biol Chem; 2004 Apr; 279(15):15376-84. PubMed ID: 14754885
[TBL] [Abstract][Full Text] [Related]
51. The structural flexibility of the human copper chaperone Atox1: Insights from combined pulsed EPR studies and computations.
Levy AR; Turgeman M; Gevorkyan-Aiapetov L; Ruthstein S
Protein Sci; 2017 Aug; 26(8):1609-1618. PubMed ID: 28543811
[TBL] [Abstract][Full Text] [Related]
52. Metal binding domains 3 and 4 of the Wilson disease protein: solution structure and interaction with the copper(I) chaperone HAH1.
Banci L; Bertini I; Cantini F; Rosenzweig AC; Yatsunyk LA
Biochemistry; 2008 Jul; 47(28):7423-9. PubMed ID: 18558714
[TBL] [Abstract][Full Text] [Related]
53. Nanobodies as Probes for Protein Dynamics in Vitro and in Cells.
Dmitriev OY; Lutsenko S; Muyldermans S
J Biol Chem; 2016 Feb; 291(8):3767-75. PubMed ID: 26677230
[TBL] [Abstract][Full Text] [Related]
54. ATP7B-Deficient Hepatocytes Reveal the Importance of Protein Misfolding Induced at Low Copper Concentration.
Charbonnier P; Chovelon B; Ravelet C; Ngo TD; Chevallet M; Deniaud A
Cells; 2022 Oct; 11(21):. PubMed ID: 36359796
[TBL] [Abstract][Full Text] [Related]
55. Characterization of mutation spectrum and identification of novel mutations in ATP7B gene from a cohort of Wilson disease patients: Functional and therapeutic implications.
Kumari N; Kumar A; Thapa BR; Modi M; Pal A; Prasad R
Hum Mutat; 2018 Dec; 39(12):1926-1941. PubMed ID: 30120852
[TBL] [Abstract][Full Text] [Related]
56. Intracellular trafficking of the human Wilson protein: the role of the six N-terminal metal-binding sites.
Cater MA; Forbes J; La Fontaine S; Cox D; Mercer JF
Biochem J; 2004 Jun; 380(Pt 3):805-13. PubMed ID: 14998371
[TBL] [Abstract][Full Text] [Related]
57. Dynamics and stability of the metal binding domains of the Menkes ATPase and their interaction with metallochaperone HAH1.
Arumugam K; Crouzy S
Biochemistry; 2012 Nov; 51(44):8885-906. PubMed ID: 23075277
[TBL] [Abstract][Full Text] [Related]
58. Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells.
Katano K; Safaei R; Samimi G; Holzer A; Tomioka M; Goodman M; Howell SB
Clin Cancer Res; 2004 Jul; 10(13):4578-88. PubMed ID: 15240550
[TBL] [Abstract][Full Text] [Related]
59. Expression, purification, and metal binding characteristics of the putative copper binding domain from the Wilson disease copper transporting ATPase (ATP7B).
DiDonato M; Narindrasorasak S; Sarkar B
Adv Exp Med Biol; 1999; 448():165-73. PubMed ID: 10079824
[No Abstract] [Full Text] [Related]
60. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.
Braiterman LT; Murthy A; Jayakanthan S; Nyasae L; Tzeng E; Gromadzka G; Woolf TB; Lutsenko S; Hubbard AL
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):E1364-73. PubMed ID: 24706876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
